Typhoid Fever among Admitted Pediatric Patients in a Tertiary Care Center: A Descriptive Cross-sectional Study. 2021

Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
Department of Clinical Pharmacology and Therapeutics, B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

BACKGROUND Typhoid fever, an acute systemic febrile illness caused by Salmonella Typhi & Paratyphi, is an important public health problem in developing countries. It requires frequent observation regarding proper diagnostic protocol and treatment practices. The aim of the study is to find the prevalence of typhoid fever among admitted pediatric patients in a tertiary care center. METHODS This is a descriptive cross-sectional study conducted among the admitted patients of pediatric and adolescent medicine of a tertiary care center from August 2016 to May 2018 after obtaining ethical clearance (IRC/609/015). Convenience sampling was used and data was analyzed using the Statistical Package of Social version 11.5. Point estimate at 95% Confidence Interval was calculated along with frequency and proportion for binary data. RESULTS Among 7450 patients, 151 (2.03%) at 95% Confidence Interval (1.71-2.35) patients were diagnosed with enteric fever of which 85 (56.29%) were male and 66 (43.71%) were female. Common symptoms were fever 151 (100%), and abdominal pain 94 (62.25%). Azithromycin 54 (38.03%) was the most common antibiotic received before presenting to hospital and ceftriaxone 151 (100%) was prescribed to all the patients after admission. Two-third of the patients (96/151) was hospitalized for at least 6 days, with the longest hospital stay of 14 days and shortest of 3 days. CONCLUSIONS Occurrence rate of Typhoid Fever was similar to other studies. Antibiotic susceptibility could not be well established; further surveillance on typhoid fever and the antimicrobial susceptibility pattern is recommended.

UI MeSH Term Description Entries
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012482 Salmonella paratyphi A A serotype of SALMONELLA ENTERICA that causes mild PARATYPHOID FEVER in humans. Salmonella paratyphi,Salmonella enterica serovar Paratyphi A
D012485 Salmonella typhi A serotype of SALMONELLA ENTERICA which is the etiologic agent of TYPHOID FEVER. Salmonella enterica serovar Typhi,Salmonella typhosa
D014435 Typhoid Fever An acute systemic febrile infection caused by SALMONELLA TYPHI, a serotype of SALMONELLA ENTERICA. Enteric Fever,Typhus, Abdominal,Salmonella typhi Infection,Typhoid,Abdominal Typhus,Enteric Fevers,Fever, Enteric,Fever, Typhoid,Fevers, Enteric,Fevers, Typhoid,Infection, Salmonella typhi,Infections, Salmonella typhi,Salmonella typhi Infections,Typhoid Fevers,Typhoids

Related Publications

Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
August 2022, JNMA; journal of the Nepal Medical Association,
Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
January 2023, JNMA; journal of the Nepal Medical Association,
Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
April 2023, JNMA; journal of the Nepal Medical Association,
Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
November 2022, JNMA; journal of the Nepal Medical Association,
Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
August 2021, JNMA; journal of the Nepal Medical Association,
Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
December 2021, JNMA; journal of the Nepal Medical Association,
Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
July 2021, JNMA; journal of the Nepal Medical Association,
Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
August 2021, JNMA; journal of the Nepal Medical Association,
Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
August 2021, JNMA; journal of the Nepal Medical Association,
Gajendra Prasad Rauniyar, and Shrawanti Bhattacharya, and Kumud Chapagain, and Gauri Shankar Shah, and Basudha Khanal
November 2022, JNMA; journal of the Nepal Medical Association,
Copied contents to your clipboard!